{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T13:20:37Z","timestamp":1705929637103},"reference-count":49,"publisher":"Akademiai Kiado Zrt.","issue":"42","license":[{"start":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:00:00Z","timestamp":1665878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2022,10,16]]},"abstract":"<jats:p>Haz\u00e1nkban mintegy 3500 ember \u00e9l transzplant\u00e1lt szervvel, az \u00f6sszes don\u00e1ci\u00f3\n                    meghaladja az \u00e9vi 400-at, ebb\u0151l a vesetranszplant\u00e1ci\u00f3k sz\u00e1ma p\u00e9ld\u00e1ul \u00e9vente\n                    250\u2013300 k\u00f6z\u00f6tt van. Az immunszuppresszi\u00f3 \u00e9s a seb\u00e9szi technik\u00e1k fejl\u0151d\u00e9s\u00e9nek\n                    k\u00f6sz\u00f6nhet\u0151en a p\u00e1ciensek t\u00fal\u00e9l\u00e9si ar\u00e1nya n\u0151, ez\u00e9rt a fogorvosoknak is egyre\n                    gyakrabban kell szembes\u00fclni\u00fck veseel\u00e9gtelens\u00e9gb\u0151l sz\u00e1rmaz\u00f3 orodentalis\n                    elv\u00e1ltoz\u00e1sok mellett az immunszuppressz\u00edv ter\u00e1pia miatt kialakul\u00f3\n                    gingiva-hyperplasi\u00e1val. A ciklosporin A alkalmaz\u00e1sa eset\u00e9n kialakult\n                    gingiva-hyperplasia prevalenci\u00e1ja a 90%-ot is el\u00e9rheti. Tanulm\u00e1nyunk c\u00e9lja\n                    felh\u00edvni a figyelmet a dentalis plakk jelent\u0151s\u00e9g\u00e9re a ciklosporin A okozta\n                    gingiva-hyperplasia kialakul\u00e1s\u00e1ban, illetve hangs\u00falyozni, hogy a\n                    gingiva-hyperplasia, valamint a szervkil\u00f6k\u0151d\u00e9s vesz\u00e9lye megel\u0151zhet\u0151 vagy\n                    nagym\u00e9rt\u00e9kben cs\u00f6kkenthet\u0151 megfelel\u0151 individu\u00e1lis sz\u00e1jhig\u00e9nia kialak\u00edt\u00e1s\u00e1val \u00e9s\n                    sikeres parodontol\u00f3giai oki ter\u00e1pia elv\u00e9gz\u00e9s\u00e9vel. K\u00fcl\u00f6n\u00f6s figyelmet \u00e9rdemel az\n                    interdiszciplin\u00e1ris egy\u00fcttm\u0171k\u00f6d\u00e9s fontoss\u00e1ga \u00e9s a p\u00e1ciensek rendszeres\n                    gondoz\u00e1sa. Vizsg\u00e1latainkat \u00e9s kezel\u00e9seinket a P\u00e9csi Tudom\u00e1nyegyetem Fog\u00e1szati \u00e9s\n                    Sz\u00e1jseb\u00e9szeti Klinik\u00e1j\u00e1nak Parodontol\u00f3giai Oszt\u00e1ly\u00e1n v\u00e9gezt\u00fck. Orv Hetil. 2022;\n                    163(42): 1663\u20131669.<\/jats:p>","DOI":"10.1556\/650.2022.32593","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T04:04:40Z","timestamp":1668830680000},"page":"1663-1669","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":2,"title":["Megel\u0151zhet\u0151-e a ciklosporin A okozta fog\u00edny-hyperplasia a dentalis plakk elt\u00e1vol\u00edt\u00e1s\u00e1val?"],"prefix":"10.1556","volume":"163","author":[{"given":"Bernadett","family":"Sch\u00f6nfeld","sequence":"first","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Fogorvostudom\u00e1nyi Kar, Klinikai K\u00f6zpont, Fog\u00e1szati \u00e9s Sz\u00e1jseb\u00e9szeti Klinika, Parodontol\u00f3giai Oszt\u00e1ly P\u00e9cs, Dischka Gy\u0151z\u0151 u. 5., 7621 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Szabadi","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Fogorvostudom\u00e1nyi Kar, Klinikai K\u00f6zpont, Fog\u00e1szati \u00e9s Sz\u00e1jseb\u00e9szeti Klinika, Parodontol\u00f3giai Oszt\u00e1ly P\u00e9cs, Dischka Gy\u0151z\u0151 u. 5., 7621 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Pint\u00e9r","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet P\u00e9cs Magyarorsz\u00e1g"},{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Szent\u00e1gothai J\u00e1nos Kutat\u00f3k\u00f6zpont, Idegtudom\u00e1nyi Centrum, Molekul\u00e1ris Farmakol\u00f3giai Csoport P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Kun","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Farmakol\u00f3giai \u00e9s Farmakoter\u00e1piai Int\u00e9zet P\u00e9cs Magyarorsz\u00e1g"},{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Szent\u00e1gothai J\u00e1nos Kutat\u00f3k\u00f6zpont, Idegtudom\u00e1nyi Centrum, Molekul\u00e1ris Farmakol\u00f3giai Csoport P\u00e9cs Magyarorsz\u00e1g"},{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Szent\u00e1gothai J\u00e1nos Kutat\u00f3k\u00f6zpont, Bioinformatika Kutat\u00f3csoport P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"B\u00e1n","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Fogorvostudom\u00e1nyi Kar, Klinikai K\u00f6zpont, Fog\u00e1szati \u00e9s Sz\u00e1jseb\u00e9szeti Klinika, Parodontol\u00f3giai Oszt\u00e1ly P\u00e9cs, Dischka Gy\u0151z\u0151 u. 5., 7621 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Vereb T, Augusztin L\u00c9, Seres L, et al. Principles of dental care of transplanted patients. [Transzplant\u00e1lt betegek fogorvosi-sz\u00e1jseb\u00e9szeti ell\u00e1t\u00e1s\u00e1nak alapelvei.] Orv Hetil. 2020; 161: 1506-1513. [Hungarian]","DOI":"10.1556\/650.2020.31828"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1600-051X.1987.tb01524.x","article-title":"A longitudinal study","volume":"14","author":"2 Seymour","year":"1987","unstructured":"2 Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol. 1987; 14: 610-613.","journal-title":"J Clin Periodontol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 P\u0151cze B, N\u00e9meth P, Langer R. Recent options in drug therapy after solid organ transplantation. [A szervtranszplant\u00e1ci\u00f3t k\u00f6vet\u0151 gy\u00f3gyszeres kezel\u00e9s \u00fajabb lehet\u0151s\u00e9gei.] Orv Hetil. 2012; 153: 1294-1301. [Hungarian]","DOI":"10.1556\/OH.2012.29343"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Kahan BD. Principles and practice of renal transplantation. CRC Press, Boca Raton, FL, 2000; 349-414.","DOI":"10.3109\/9780203417348"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jobcr.2018.10.004","article-title":"Cyclosporine A - Induced gingival overgrowth and proliferating cell nuclear antigen expression in experimental periodontitis","volume":"9","author":"5 Ricardo","year":"2019","unstructured":"5 Ricardo LH, do Prado RF, Carvalho YR, et al. Cyclosporine A - Induced gingival overgrowth and proliferating cell nuclear antigen expression in experimental periodontitis. J Oral Biol Craniofac Res. 2019; 9: 86-90.","journal-title":"J Oral Biol Craniofac Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.17796\/jcpd.26.1.e2g5662851133t35","article-title":"Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by cyclosporine","volume":"26","author":"Irshied J","year":"2001","unstructured":"6 Irshied J, Bimstein E. Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by cyclosporine. J Clin Pediatr Dent. 2001; 26: 93-98.","journal-title":"J Clin Pediatr Dent"},{"key":"ref6","unstructured":"7 Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009; 23(Suppl 2): 5-70. Erratum: J Eur Acad Dermatol Venereol. 2010; 24: 117-118."},{"issue":"8151","key":"ref7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(79)92440-1","article-title":"Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers","volume":"314","author":"8 Calne","year":"1979","unstructured":"8 Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 314(8151): 1033-1036.","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1600-051X.1983.tb01272.x","article-title":"Initial observation that cyclosporin-A induces gingival enlargement in man","volume":"10","author":"9 Rateitschak-Pl\u00fcss","year":"1983","unstructured":"9 Rateitschak-Pl\u00fcss EM, Hefti A, L\u00f6rtscher R, et al. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol. 1983; 10: 237-246.","journal-title":"J Clin Periodontol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0030-4220(86)90291-4","article-title":"Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia","volume":"62","author":"10 Daley","year":"1986","unstructured":"10 Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol. 1986; 62: 417-421.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"ref10","unstructured":"11 Jepsen S, Caton JG, Albandar JM, et al. Periodontal manifestations of systemic diseases and developmental and acquired conditions: consensus report of workgroup 3 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol. 2018; 45(Suppl 20): S219-S229."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12 Nanda T, Singh B, Sharma P, et al. Cyclosporine A and amlodipine induced gingival overgrowth in a kidney transplant recipient: case presentation with literature review. BMJ Case Rep. 2019; 12: e229587.","DOI":"10.1136\/bcr-2019-229587"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/ijms21020595","article-title":"Role of cyclosporine in gingival hiperplasia: an in vitro study on gingival fibroblasts","volume":"21","author":"13 Lauritano","year":"2020","unstructured":"13 Lauritano D, Palmieri A, Lucchese A, et al. Role of cyclosporine in gingival hiperplasia: an in vitro study on gingival fibroblasts. Int J Mol Sci. 2020; 21: 595.","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1902\/jop.2004.75.10.1424","article-title":"Informational paper: drug-associated gingival enlargement","volume":"75","author":"Dongari-Bagtzoglou A. Research","year":"2004","unstructured":"14 Dongari-Bagtzoglou A. Research, Science and Therapy Committee, American Academy of Periodontology. Informational paper: drug-associated gingival enlargement. J Periodontol. 2004; 75: 1424-1431.","journal-title":"J Periodontol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antibiotics8030124","article-title":"Periodontal microbiological status influences the occurrence of cyclosporine-A and tacrolimus-induced gingival overgrowth","volume":"8","author":"15 Rapone","year":"2019","unstructured":"15 Rapone B, Ferrara E, Santacroce L, et al. Periodontal microbiological status influences the occurrence of cyclosporine-A and tacrolimus-induced gingival overgrowth. Antibiotics (Basel) 2019; 8: 124.","journal-title":"Antibiotics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16 Cseke \u00c1, Filep A, Kar\u00e1csonyi B, et al. Prevention and non-surgical periodontal therapy of calcium channel blockers induced severe gingival overgrowth. [A kalciumcsatorna-blokkol\u00f3 gy\u00f3gyszerek \u00e1ltal induk\u00e1lt s\u00falyos gingivahyperplasia konzervat\u00edv kezel\u00e9se \u00e9s megel\u0151z\u00e9s\u00e9nek lehet\u0151s\u00e9gei.] Orv Hetil. 2022; 163: 506-512. [Hungarian]","DOI":"10.1556\/650.2022.32385"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0140-6736(87)91094-4","article-title":"Cyclosporin, nifedipine, and gingival hyperplasia","volume":"330","author":"Slavin J","year":"1987","unstructured":"17 Slavin J, Taylor J. Cyclosporin, nifedipine, and gingival hyperplasia. Lancet 1987; 330: 739.","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1902\/jop.2000.71.10.1630","article-title":"Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus","volume":"71","author":"18 Hern\u00e1ndez","year":"2000","unstructured":"18 Hern\u00e1ndez G, Arriba L, Lucas M, et al. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol. 2000; 71: 1630-1636.","journal-title":"J Periodontol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.transproceed.2019.03.009","article-title":"Oral health status of kidney transplant patients","volume":"51","author":"19 Sch\u00f6nfeld","year":"2019","unstructured":"19 Sch\u00f6nfeld B, Varga \u00c1, Szak\u00e1ly P, et al. Oral health status of kidney transplant patients. Transplant Proc. 2019; 51: 1248-1250.","journal-title":"Transplant Proc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1399-0012.2008.00931.x","article-title":"The influence of chronic periodontitis on serum TNF-\u03b1, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients","volume":"23","author":"20 Blach","year":"2009","unstructured":"20 Blach A, Franek E, Witula A, et al. The influence of chronic periodontitis on serum TNF-\u03b1, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients. Clin Transplant. 2009; 23: 213-219.","journal-title":"Clin Transplant"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.TP.0000158716.12065.24","article-title":"Association between chronic periodontal disease and left ventricular hypertrophy in kidney transplant recipients","volume":"80","author":"21 Franek","year":"2005","unstructured":"21 Franek E, Blach A, Witula A, et al. Association between chronic periodontal disease and left ventricular hypertrophy in kidney transplant recipients. Transplantation 2005; 80: 3-5.","journal-title":"Transplantation"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22 Zwiech R, Bruzda-Zwiech A. Does oral health contribute to post-transplant complications in kidney allograft recipients? Acta Odontol Scand. 2013; 71: 756-763.","DOI":"10.3109\/00016357.2012.715203"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1536\/jhj.45.183","article-title":"Interleukin-6 and cardiovascular diseases","volume":"45","author":"Kanda T","year":"2004","unstructured":"23 Kanda T, Takahashi T. Interleukin-6 and cardiovascular diseases. Jpn Heart J. 2004; 45: 183-193.","journal-title":"Jpn Heart J"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Mann DL. Tumor necrosis factor-induced signal transduction and left ventricular remodeling. J Card Fail. 2022; 8(6 Suppl): S379-S386.","DOI":"10.1054\/jcaf.2002.129253"},{"key":"ref24","unstructured":"25 Moffitt ML, Bencivenni D, Cohen RE. Drug-induced gingival enlargement: an overview. Compend Contin Educ Dent. 2013; 34: 330-336."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bdj.4805474","article-title":"Gingival hyperplasia induced by cyclosporin-A","volume":"157","author":"Tyldesley W","year":"1984","unstructured":"26 Tyldesley W, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J. 1984; 157: 305-309.","journal-title":"Br Dent J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1902\/jop.1994.65.8.744","article-title":"Gingival overgrowth in cyclosporine A treated multiple sclerosis patients","volume":"65","author":"27 Hefti","year":"1994","unstructured":"27 Hefti AF, Eshenaur AE, Hassell TM, et al. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol. 1994; 65: 744-749.","journal-title":"J Periodontol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1600-051x.2000.027004217.x","article-title":"Risk factors for drug-induced gingival overgrowth","volume":"27","author":"28 Seymour","year":"2000","unstructured":"28 Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000; 27: 217-223.","journal-title":"J Clin Periodontol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0022034515571265","article-title":"Molecular and clinical aspects of drug-induced gingival overgrowth","volume":"94","author":"Trackman PC","year":"2015","unstructured":"29 Trackman PC, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res. 2015; 94: 540-546.","journal-title":"J Dent Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1902\/jop.1999.70.6.587","article-title":"Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia","volume":"70","author":"30 Kantarci","year":"1999","unstructured":"30 Kantarci A, Cebeci I, Tuncer \u00d6, et al. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol. 1999; 70: 587-593.","journal-title":"J Periodontol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1902\/jop.2001.72.7.921","article-title":"Connective tissue growth factor in drug-induced gingival overgrowth","volume":"72","author":"31 Uzel","year":"2001","unstructured":"31 Uzel MI, Kantarci A, Hong HH, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol. 2001; 72: 921-931.","journal-title":"J Periodontol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1600-0765.2011.01450.x","article-title":"Cyclosporine-A inhibits MMP-2 and -9 activities in the presence of Porphyromonas gingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co-culture","volume":"47","author":"32 Kuo","year":"2012","unstructured":"32 Kuo PJ, Tu HP, Chin YT, et al. Cyclosporine-A inhibits MMP-2 and -9 activities in the presence of Porphyromonas gingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co-culture. J Periodontal Res. 2012; 47: 431-438.","journal-title":"J Periodontal Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1600-051X.2010.01601.x","article-title":"Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus","volume":"37","author":"33 Cota","year":"2010","unstructured":"33 Cota LO, Aquino DR, Franco GC, et al. Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus. J Clin Periodontol. 2010; 37: 894-902.","journal-title":"J Clin Periodontol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"9570","DOI":"10.1073\/pnas.92.21.9570","article-title":"A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet\u2011derived growth factor B gene","volume":"92","author":"34 Yoshida","year":"1995","unstructured":"34 Yoshida M, Sakuma J, Hayashi S, et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet\u2011derived growth factor B gene. Proc Natl Acad Sci USA 1995; 92: 9570-9574.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1073\/pnas.0409722102","article-title":"Platelet\u2011derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma","volume":"102","author":"35 Campbell","year":"2005","unstructured":"35 Campbell JS, Hughes SD, Gilbertson DG, et al. Platelet\u2011derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 2005; 102: 3389-3394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"36 Czochra","year":"2006","unstructured":"36 Czochra P, Klopcic B, Meyer E, et al. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol. 2006; 45: 419-428.","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0765.2004.00762.x","article-title":"Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A","volume":"40","author":"37 Yoshida","year":"2005","unstructured":"37 Yoshida T, Nagata J, Yamane A. Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A. J Periodontal Res. 2005; 40: 11-19.","journal-title":"J Periodontal Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"38 Wynn","year":"2008","unstructured":"38 Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214: 199-210.","journal-title":"J Pathol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.3390\/ijms20143413","article-title":"Pathological characteristics of periodontal disease in patients with chronic kidney disease and kidney transplantation","volume":"20","author":"39 Kitamura","year":"2019","unstructured":"39 Kitamura M, Mochizuki Y, Miyata Y, et al. Pathological characteristics of periodontal disease in patients with chronic kidney disease and kidney transplantation. Int J Mol Sci. 2019; 20: 3413.","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40 Schmalz G, Berisha L, Wendorff H, et al. Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation. Med Oral Patol Oral Cir Bucal. 2018; 23: e326- e334.","DOI":"10.4317\/medoral.22238"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.transproceed.2012.12.007","article-title":"The role of MDR1 C3435T gene polymorphism on gingival hyperplasia in Turkish renal transplant patients treated with cyclosporine in the absence of calcium channel blockers","volume":"45","author":"41 Kazancioglu","year":"2013","unstructured":"41 Kazancioglu HO, Ak G, Turkmen A, et al. The role of MDR1 C3435T gene polymorphism on gingival hyperplasia in Turkish renal transplant patients treated with cyclosporine in the absence of calcium channel blockers. Transplant Proc. 2013; 45: 2233-2237.","journal-title":"Transplant Proc"},{"key":"ref41","unstructured":"42 Ciavarella D, Guiglia R, Campisi G, et al. Update on gingival overgrowth by cyclosporine A Update on gingival overgrowth by cyclosporine A in renal transplants. Med Oral Patol Oral Cir Bucal 2007; 12: E19-E25."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ijmm.2015.2144","article-title":"Cellular crosstalk mechanism of Toll-like receptors in gingival overgrowth (Review)","volume":"35","author":"43 Subramani","year":"2015","unstructured":"43 Subramani T, Rathnavelu V, Alitheen NB, et al. Cellular crosstalk mechanism of Toll-like receptors in gingival overgrowth (Review). Int J Mol Med. 2015; 35: 1151-1158.","journal-title":"Int J Mol Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1902\/jop.2003.74.4.437","article-title":"The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts","volume":"74","author":"44 Hyland","year":"2003","unstructured":"44 Hyland PL, Traynor PS, Myrillas TT, et al. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol. 2003; 74: 437-445.","journal-title":"J Periodontol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1902\/jop.2002.73.11.1313","article-title":"Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation","volume":"73","author":"45 Cotrim","year":"2002","unstructured":"45 Cotrim P, de Andrade CR, Martelli-Junior H, et al. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation. J Periodontol. 2002; 73: 1313-1322.","journal-title":"J Periodontol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4103\/jomfp.JOMFP_50_20","article-title":"Rare phenomena of tacrolimus-induced gingival hyperplasia","volume":"24","author":"46 Nivethitha","year":"2020","unstructured":"46 Nivethitha K, Ramesh A, Talwar A, et al. Rare phenomena of tacrolimus-induced gingival hyperplasia. J Oral Maxillofac Pathol. 2020; 24: 403.","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref46","unstructured":"47 Shrestha BM. Two decades of tacrolimus in renal transplant: basic science and clinical evidences. Exp Clin Transplant. 2017; 15: 1-9."},{"key":"ref47","unstructured":"48 Kov\u00e1cs, T, Wagner, L. Treatment of hypertension in kidney transplant patients. [Magas v\u00e9rnyom\u00e1s kezel\u00e9se vesetranszplant\u00e1lt betegekn\u00e9l.] Hyperton Nephrol. 2018; 22: 148-153. [Hungarian]"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49 Varga, \u00c1, Kalm\u00e1r Nagy K, Szak\u00e1ly, P. Tacrolimus therapy after renal transplantation. Current questions of concentration\/dose ratio. [Takrolimuszter\u00e1pia vesetranszplant\u00e1ci\u00f3 ut\u00e1n. A koncentr\u00e1ci\u00f3\/d\u00f3zis ar\u00e1ny aktu\u00e1lis k\u00e9rd\u00e9sei.] Orv Hetil. 2019; 160: 1178-1183. [Hungarian]","DOI":"10.1556\/650.2019.31470"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/42\/article-p1663.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/42\/article-p1663.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/42\/article-p1663.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T16:08:10Z","timestamp":1698336490000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/42\/article-p1663.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,16]]},"references-count":49,"journal-issue":{"issue":"42"},"URL":"https:\/\/doi.org\/10.1556\/650.2022.32593","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,16]]}}}